We are live on ! Find out more
P8IP

Pier 88 Investment Partners Portfolio holdings

AUM $421M
1-Year Est. Return 14.71%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+14.71%
3 Year Est. Return
+36.1%
5 Year Est. Return
+43.13%
10 Year Est. Return
AUM
$508M
AUM Growth
+$54.2M
Cap. Flow
-$279M
Cap. Flow %
-54.83%
Top 10 Hldgs %
45.8%
Holding
102
New
11
Increased
23
Reduced
32
Closed
6

Top Sells

Rank Stock Value
1
COHR icon
Coherent
COHR
+$4.89M
2
MELI icon
Mercado Libre
MELI
+$3.41M
3
TDG icon
TransDigm Group
TDG
+$3.32M
4
KBR icon
KBR
KBR
+$3.3M
5
FOUR icon
Shift4
FOUR
+$2.02M

Sector Composition

Rank Sector Weight
1 Technology 6.32%
2 Consumer Discretionary 3.07%
3 Industrials 2.31%
4 Healthcare 2%
5 Financials 0.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOV icon
26
Dover
DOV
$28.2B
$1.24M 0.24%
6,593
HCAT icon
27
Health Catalyst
HCAT
$129M
$1.21M 0.24%
170,890
+7,450
+5% +$59.3K
TYL icon
28
Tyler Technologies
TYL
$13.3B
$1.19M 0.23%
2,070
-10
-0.5% -$6.04K
GTLS
29
DELISTED
Chart Industries
GTLS
$1.1M 0.22%
5,790
+2,120
+58% +$341K
RXRX icon
30
Recursion Pharmaceuticals
RXRX
$1.8B
$1.09M 0.22%
161,730
+27,820
+21% +$187K
COIN icon
31
Coinbase
COIN
$39.1B
$1.05M 0.21%
+4,210
New +$1.07M
EEFT icon
32
Euronet Worldwide
EEFT
$2.65B
$1.03M 0.2%
9,971
-510
-5% -$51.9K
MELI icon
33
Mercado Libre
MELI
$97.7B
$952K 0.19%
560
-1,753
-76% -$3.41M
RYAN icon
34
Ryan Specialty Holdings
RYAN
$10.8B
$947K 0.19%
+14,760
New +$1.03M
DKNG icon
35
DraftKings
DKNG
$12.5B
$933K 0.18%
25,080
-9,220
-27% -$366K
DNLI icon
36
Denali Therapeutics
DNLI
$4.01B
$925K 0.18%
45,410
-13,760
-23% -$352K
ANET icon
37
Arista Networks
ANET
$246B
$867K 0.17%
7,840
-8,280
-51% -$851K
SYNA icon
38
Synaptics
SYNA
$4.16B
$771K 0.15%
10,105
-1,010
-9% -$76.5K
PRCT icon
39
Procept Biorobotics
PRCT
$1.26B
$759K 0.15%
+9,430
New +$806K
FPI
40
Farmland Partners
FPI
$428M
$759K 0.15%
64,530
+8,080
+14% +$94.8K
ON icon
41
ON Semiconductor
ON
$31.6B
$748K 0.15%
11,860
-4,520
-28% -$311K
ABCL icon
42
AbCellera Biologics
ABCL
$3.01B
$694K 0.14%
236,900
+41,400
+21% +$115K
OKTA icon
43
Okta
OKTA
$26B
$668K 0.13%
8,480
+1,830
+28% +$142K
SLAB icon
44
Silicon Laboratories
SLAB
$7.21B
$642K 0.13%
5,172
-700
-12% -$80.3K
NBIX icon
45
Neurocrine Biosciences
NBIX
$16.6B
$640K 0.13%
4,690
+1,600
+52% +$198K
IWO icon
46
iShares Russell 2000 Growth ETF
IWO
$14.9B
$633K 0.12%
2,200
WTTR icon
47
Select Water Solutions
WTTR
$2.7B
$615K 0.12%
+46,470
New +$591K
RARE icon
48
Ultragenyx Pharmaceutical
RARE
$2.66B
$593K 0.12%
14,090
-8,450
-37% -$419K
KRYS icon
49
Krystal Biotech
KRYS
$9.77B
$587K 0.12%
3,750
+220
+6% +$39K
ABSI icon
50
Absci
ABSI
$1.56B
$553K 0.11%
211,210
+75,090
+55% +$264K

Similar funds

Pier 88 Investment Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Pier 88 Investment Partners held 102 positions worth $508M, up 12% from $454M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Pier 88 Investment Partners withdrew a net $279M in Q4 2024, closing 6 positions and reducing 32 holdings. Its most notable exit was KBR, an estimated $3.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 7.6% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Pier 88 Investment Partners opened a new position in Alphabet (Google) Class A worth $3.07M.

  • Pier 88 Investment Partners's largest Q4 2024 buy was Alphabet (Google) Class A: 16,200 shares worth $3.07M.
  • Pier 88 Investment Partners added most to Hewlett Packard Enterprise 7.625% Series C Preferred Stock in Q4 2024, an estimated $5.96M increase.
  • Pier 88 Investment Partners's biggest Q4 2024 reduction was Coherent, cutting an estimated $4.89M.
  • Pier 88 Investment Partners fully exited KBR in Q4 2024, selling an estimated $3.3M.
  • Pier 88 Investment Partners's ten largest holdings make up 46% of its $508M portfolio in Q4 2024.
  • Pier 88 Investment Partners opened 11 new positions and closed 6 in Q4 2024.
  • Pier 88 Investment Partners's portfolio value rose 12% quarter-over-quarter to $508M.

Based on Pier 88 Investment Partners's 13F filing for Q4 2024, filed 12 Feb 2025.